Skip Navigation LinksHome > March 2009 - Volume 33 - Issue 3 > TTF-1 Expression in Nephroblastoma
American Journal of Surgical Pathology:
doi: 10.1097/PAS.0b013e318185d21b
Original Articles

TTF-1 Expression in Nephroblastoma

Bisceglia, Michele MD*; Ragazzi, Moira MD† ‡; Galliani, Carlos A. MD§; Lastilla, Gaetano MD; Rosai, Juan MD

Collapse Box


The unexpected observation of nuclear immunoreactivity for thyroid transcription factor-1 (TTF-1) associated with an apparent lack of nuclear immunoreactivity for Wilms tumor-1 protein (WT1) in the pulmonary metastasis of a morphologically typical case of nephroblastoma affecting a 6.5-year-old male prompted us to examine the expression of these 2 markers (and CD56) in a series of 48 nephroblastomas, 5 adult metanephric adenomas, and 1 pediatric cystic nephroma. TTF-1 was found to be positive in 8 of 48 (16.6%) nephroblastomas and negative in all 5 metanephric adenomas. WT1 was positive in 43 of 48 (89.6%) nephroblastomas and 4 of 5 (80.0%) metanephric adenomas. CD56 was positive in 45 of 47 cases that were so tested (95.74%), but negative in all metanephric adenomas. The single cystic nephroma was TTF-1–negative, WT1–negative, and CD56-positive. The finding of TTF-1 expression in one sixth of nephroblastomas constitutes a potential source of misdiagnosis. The biologic significance of this surprising finding is unclear. It may reflect the embryonal nature of these tumors and may conceivably result—directly or indirectly—in interference with the transcriptional control of target genes and other molecular events in the pathway leading to the development of nephroblastoma.

© 2009 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.